6550 Polaris Pharmaceuticals-KY (Private Placement Completion)
Polaris Pharmaceuticals-KY (6550) announced the completion of its 2nd private placement of common shares for the 114th fiscal year. The company issued 34.9 million shares at 18 TWD per share, raising 628.2 million TWD. Payment was completed on May 22, which is also the capital increase record date.
📋 Article Processing Timeline
- 📰 Published: May 23, 2026 at 06:31
- 🔍 Collected: May 23, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 21:07 (206h 36m after Collected)
Polaris Pharmaceuticals Group (6550) announced on May 22, 2026, that it has completed the payment for its 2nd private placement of common shares for the 114th fiscal year, setting the capital increase record date to the same day. The company issued 34,900,000 shares at a price of 18 TWD per share, totaling 628,200,000 TWD. This capital increase was conducted within the limit of 150,000,000 shares approved by the extraordinary shareholders' meeting on December 26, 2025. All funds have been fully collected.
FAQ
What is the private placement price for Polaris Pharmaceuticals?
18 TWD per share.